Uncomplicated skin infections account for almost 200 million ... The primary etiology of these infections is Staphylococcus aureus, over 60% of which is estimated to be methicillin resistant ...

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and ...

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and ...

The multivalent toxoid vaccine candidate from LimmaTech Biologics AG is designed to prevent skin and soft-tissue infections ...

A staph infection is a type of skin infection that occurs by bacteria ... a staph infection may develop into methicillin-resistant Staphylococcus aureus, or MRSA, which can become deadly as ...

cSSSI: Complicated skin and skin-structure infection; ESBL: Extended spectrum β lactamase; MRSA: Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-susceptible Staphylococcus aureus.

“It is a pathogen in dire need of control because it causes significant morbidity and mortality not just in the United States ...

We are very pleased with our collaboration with Innoviva Specialty Therapeutics for the commercialization of Zevtera in the US. The company is a highly committed, focused and capable partner that ...

Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...

LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has grant ...